Role of GABA-active neurosteroids in the efficacy of metyrapone against cocaine addiction
•The rapid actions and pharmacological mechanisms of metyrapone were investigated in a rat model of cocaine addiction.•Metyrapone decreased cocaine self-administration in a dose-dependent manner.•Bicuculline, a GABAA receptor antagonist, partially attenuates metyrapone's effects on cocaine self...
Gespeichert in:
Veröffentlicht in: | Behavioural brain research 2014-09, Vol.271, p.269-276 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 276 |
---|---|
container_issue | |
container_start_page | 269 |
container_title | Behavioural brain research |
container_volume | 271 |
creator | Schmoutz, Christopher D. Guerin, Glenn F. Goeders, Nicholas E. |
description | •The rapid actions and pharmacological mechanisms of metyrapone were investigated in a rat model of cocaine addiction.•Metyrapone decreased cocaine self-administration in a dose-dependent manner.•Bicuculline, a GABAA receptor antagonist, partially attenuates metyrapone's effects on cocaine self-administration.•Finasteride, a 5alpha-reductase inhibitor, affected cocaine self-administration as well.•These results suggest that metyrapone may act via GABA-active steroid metabolites to decrease cocaine self-administration.
Previous research has demonstrated a complicated role for stress and HPA axis activation in potentiating various cocaine-related behaviors in preclinical models of drug dependence. However, the investigation of several antiglucocorticoid therapies has yielded equivocal results in reducing cocaine-related behaviors, possibly because of varying mechanisms of actions. Specifically, research suggests that metyrapone (a corticosterone synthesis inhibitor) may reduce cocaine self-administration in rats via a nongenomic, extra-adrenal mechanism without altering plasma corticosterone. In the current experiments, male rats were trained to self-administer cocaine infusions and food pellets in a multiple, alternating schedule of reinforcement. Metyrapone pretreatment dose-dependently decreased cocaine self-administration as demonstrated previously. Pharmacological inhibition of neurosteroid production by finasteride had significant effects on cocaine self-administration, regardless of metyrapone pretreatment. However, metyrapone's effects on cocaine self-administration were significantly attenuated with bicuculline pretreatment, suggesting a role for GABA-active neurosteroids in cocaine-reinforced behaviors. In vitro binding data also confirmed that metyrapone does not selectively bind to GABA-related proteins. The results of these experiments support the hypothesis that metyrapone may increase neurosteroidogenesis to produce effects on cocaine-related behaviors. |
doi_str_mv | 10.1016/j.bbr.2014.06.032 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1627963031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432814004069</els_id><sourcerecordid>1627963031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-17154874830b63dc9db6234822b6f46669a3101f0126549bcdd63e468db81f703</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVpaLZpf0AvwZdCL3b05bFMT5vQJoFAICSHnoQsjVotXmsreQP776Nlt-ktJ43gmZd5H0K-MNowyuBi1QxDajhlsqHQUMHfkQVTHa-7VvbvyaIwUEvB1Sn5mPOKUippyz6QUy77tldtvyC_HuKIVfTV9fJyWRs7h2esJtymmGdMMbhchama_2CF3gdr7G4Pr3HeJbOJE1bmtwlTnisbbRnK37lQUuL0iZx4M2b8fHzPyNPPH49XN_Xd_fXt1fKutpLBXLOOtVJ1Ugk6gHC2dwNwIRXnA3gJAL0RpaynjENpNVjnQKAE5QbFfEfFGfl2yN2k-HeLedbrkC2Oo5kwbrNmwLseBBWsoOyA2lIvJ_R6k8LapJ1mVO-N6pUuRvXeqKagi9Gyc36M3w5rdK8b_xQW4OsRMNma0Scz2ZD_cwoYBQaF-37gsMh4Dph0tgEniy4ktLN2MbxxxgsZiZHD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1627963031</pqid></control><display><type>article</type><title>Role of GABA-active neurosteroids in the efficacy of metyrapone against cocaine addiction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Schmoutz, Christopher D. ; Guerin, Glenn F. ; Goeders, Nicholas E.</creator><creatorcontrib>Schmoutz, Christopher D. ; Guerin, Glenn F. ; Goeders, Nicholas E.</creatorcontrib><description>•The rapid actions and pharmacological mechanisms of metyrapone were investigated in a rat model of cocaine addiction.•Metyrapone decreased cocaine self-administration in a dose-dependent manner.•Bicuculline, a GABAA receptor antagonist, partially attenuates metyrapone's effects on cocaine self-administration.•Finasteride, a 5alpha-reductase inhibitor, affected cocaine self-administration as well.•These results suggest that metyrapone may act via GABA-active steroid metabolites to decrease cocaine self-administration.
Previous research has demonstrated a complicated role for stress and HPA axis activation in potentiating various cocaine-related behaviors in preclinical models of drug dependence. However, the investigation of several antiglucocorticoid therapies has yielded equivocal results in reducing cocaine-related behaviors, possibly because of varying mechanisms of actions. Specifically, research suggests that metyrapone (a corticosterone synthesis inhibitor) may reduce cocaine self-administration in rats via a nongenomic, extra-adrenal mechanism without altering plasma corticosterone. In the current experiments, male rats were trained to self-administer cocaine infusions and food pellets in a multiple, alternating schedule of reinforcement. Metyrapone pretreatment dose-dependently decreased cocaine self-administration as demonstrated previously. Pharmacological inhibition of neurosteroid production by finasteride had significant effects on cocaine self-administration, regardless of metyrapone pretreatment. However, metyrapone's effects on cocaine self-administration were significantly attenuated with bicuculline pretreatment, suggesting a role for GABA-active neurosteroids in cocaine-reinforced behaviors. In vitro binding data also confirmed that metyrapone does not selectively bind to GABA-related proteins. The results of these experiments support the hypothesis that metyrapone may increase neurosteroidogenesis to produce effects on cocaine-related behaviors.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2014.06.032</identifier><identifier>PMID: 24959859</identifier><identifier>CODEN: BBREDI</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>5-alpha Reductase Inhibitors - administration & dosage ; 5-alpha Reductase Inhibitors - pharmacology ; Animals ; Bicuculline ; Bicuculline - administration & dosage ; Bicuculline - pharmacology ; Biological and medical sciences ; Cocaine ; Cocaine - administration & dosage ; Cocaine - pharmacology ; Cocaine-Related Disorders - drug therapy ; Cocaine-Related Disorders - metabolism ; Conditioning, Operant - drug effects ; Drug-Seeking Behavior - drug effects ; Enzyme Inhibitors - pharmacology ; Finasteride ; Finasteride - administration & dosage ; Finasteride - pharmacology ; Food ; Fundamental and applied biological sciences. Psychology ; GABA ; GABA-A Receptor Antagonists - administration & dosage ; GABA-A Receptor Antagonists - pharmacology ; Male ; Medical sciences ; Metyrapone ; Metyrapone - pharmacology ; Neuropharmacology ; Neurosteroid ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Wistar ; Reinforcement (Psychology) ; Self Administration - methods ; Vertebrates: nervous system and sense organs</subject><ispartof>Behavioural brain research, 2014-09, Vol.271, p.269-276</ispartof><rights>2014 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-17154874830b63dc9db6234822b6f46669a3101f0126549bcdd63e468db81f703</citedby><cites>FETCH-LOGICAL-c416t-17154874830b63dc9db6234822b6f46669a3101f0126549bcdd63e468db81f703</cites><orcidid>0000-0002-6901-3227</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0166432814004069$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28610616$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24959859$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmoutz, Christopher D.</creatorcontrib><creatorcontrib>Guerin, Glenn F.</creatorcontrib><creatorcontrib>Goeders, Nicholas E.</creatorcontrib><title>Role of GABA-active neurosteroids in the efficacy of metyrapone against cocaine addiction</title><title>Behavioural brain research</title><addtitle>Behav Brain Res</addtitle><description>•The rapid actions and pharmacological mechanisms of metyrapone were investigated in a rat model of cocaine addiction.•Metyrapone decreased cocaine self-administration in a dose-dependent manner.•Bicuculline, a GABAA receptor antagonist, partially attenuates metyrapone's effects on cocaine self-administration.•Finasteride, a 5alpha-reductase inhibitor, affected cocaine self-administration as well.•These results suggest that metyrapone may act via GABA-active steroid metabolites to decrease cocaine self-administration.
Previous research has demonstrated a complicated role for stress and HPA axis activation in potentiating various cocaine-related behaviors in preclinical models of drug dependence. However, the investigation of several antiglucocorticoid therapies has yielded equivocal results in reducing cocaine-related behaviors, possibly because of varying mechanisms of actions. Specifically, research suggests that metyrapone (a corticosterone synthesis inhibitor) may reduce cocaine self-administration in rats via a nongenomic, extra-adrenal mechanism without altering plasma corticosterone. In the current experiments, male rats were trained to self-administer cocaine infusions and food pellets in a multiple, alternating schedule of reinforcement. Metyrapone pretreatment dose-dependently decreased cocaine self-administration as demonstrated previously. Pharmacological inhibition of neurosteroid production by finasteride had significant effects on cocaine self-administration, regardless of metyrapone pretreatment. However, metyrapone's effects on cocaine self-administration were significantly attenuated with bicuculline pretreatment, suggesting a role for GABA-active neurosteroids in cocaine-reinforced behaviors. In vitro binding data also confirmed that metyrapone does not selectively bind to GABA-related proteins. The results of these experiments support the hypothesis that metyrapone may increase neurosteroidogenesis to produce effects on cocaine-related behaviors.</description><subject>5-alpha Reductase Inhibitors - administration & dosage</subject><subject>5-alpha Reductase Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Bicuculline</subject><subject>Bicuculline - administration & dosage</subject><subject>Bicuculline - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cocaine</subject><subject>Cocaine - administration & dosage</subject><subject>Cocaine - pharmacology</subject><subject>Cocaine-Related Disorders - drug therapy</subject><subject>Cocaine-Related Disorders - metabolism</subject><subject>Conditioning, Operant - drug effects</subject><subject>Drug-Seeking Behavior - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Finasteride</subject><subject>Finasteride - administration & dosage</subject><subject>Finasteride - pharmacology</subject><subject>Food</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GABA</subject><subject>GABA-A Receptor Antagonists - administration & dosage</subject><subject>GABA-A Receptor Antagonists - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metyrapone</subject><subject>Metyrapone - pharmacology</subject><subject>Neuropharmacology</subject><subject>Neurosteroid</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reinforcement (Psychology)</subject><subject>Self Administration - methods</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVpaLZpf0AvwZdCL3b05bFMT5vQJoFAICSHnoQsjVotXmsreQP776Nlt-ktJ43gmZd5H0K-MNowyuBi1QxDajhlsqHQUMHfkQVTHa-7VvbvyaIwUEvB1Sn5mPOKUippyz6QUy77tldtvyC_HuKIVfTV9fJyWRs7h2esJtymmGdMMbhchama_2CF3gdr7G4Pr3HeJbOJE1bmtwlTnisbbRnK37lQUuL0iZx4M2b8fHzPyNPPH49XN_Xd_fXt1fKutpLBXLOOtVJ1Ugk6gHC2dwNwIRXnA3gJAL0RpaynjENpNVjnQKAE5QbFfEfFGfl2yN2k-HeLedbrkC2Oo5kwbrNmwLseBBWsoOyA2lIvJ_R6k8LapJ1mVO-N6pUuRvXeqKagi9Gyc36M3w5rdK8b_xQW4OsRMNma0Scz2ZD_cwoYBQaF-37gsMh4Dph0tgEniy4ktLN2MbxxxgsZiZHD</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Schmoutz, Christopher D.</creator><creator>Guerin, Glenn F.</creator><creator>Goeders, Nicholas E.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><orcidid>https://orcid.org/0000-0002-6901-3227</orcidid></search><sort><creationdate>20140901</creationdate><title>Role of GABA-active neurosteroids in the efficacy of metyrapone against cocaine addiction</title><author>Schmoutz, Christopher D. ; Guerin, Glenn F. ; Goeders, Nicholas E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-17154874830b63dc9db6234822b6f46669a3101f0126549bcdd63e468db81f703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>5-alpha Reductase Inhibitors - administration & dosage</topic><topic>5-alpha Reductase Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Bicuculline</topic><topic>Bicuculline - administration & dosage</topic><topic>Bicuculline - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cocaine</topic><topic>Cocaine - administration & dosage</topic><topic>Cocaine - pharmacology</topic><topic>Cocaine-Related Disorders - drug therapy</topic><topic>Cocaine-Related Disorders - metabolism</topic><topic>Conditioning, Operant - drug effects</topic><topic>Drug-Seeking Behavior - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Finasteride</topic><topic>Finasteride - administration & dosage</topic><topic>Finasteride - pharmacology</topic><topic>Food</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GABA</topic><topic>GABA-A Receptor Antagonists - administration & dosage</topic><topic>GABA-A Receptor Antagonists - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metyrapone</topic><topic>Metyrapone - pharmacology</topic><topic>Neuropharmacology</topic><topic>Neurosteroid</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reinforcement (Psychology)</topic><topic>Self Administration - methods</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmoutz, Christopher D.</creatorcontrib><creatorcontrib>Guerin, Glenn F.</creatorcontrib><creatorcontrib>Goeders, Nicholas E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmoutz, Christopher D.</au><au>Guerin, Glenn F.</au><au>Goeders, Nicholas E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of GABA-active neurosteroids in the efficacy of metyrapone against cocaine addiction</atitle><jtitle>Behavioural brain research</jtitle><addtitle>Behav Brain Res</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>271</volume><spage>269</spage><epage>276</epage><pages>269-276</pages><issn>0166-4328</issn><eissn>1872-7549</eissn><coden>BBREDI</coden><abstract>•The rapid actions and pharmacological mechanisms of metyrapone were investigated in a rat model of cocaine addiction.•Metyrapone decreased cocaine self-administration in a dose-dependent manner.•Bicuculline, a GABAA receptor antagonist, partially attenuates metyrapone's effects on cocaine self-administration.•Finasteride, a 5alpha-reductase inhibitor, affected cocaine self-administration as well.•These results suggest that metyrapone may act via GABA-active steroid metabolites to decrease cocaine self-administration.
Previous research has demonstrated a complicated role for stress and HPA axis activation in potentiating various cocaine-related behaviors in preclinical models of drug dependence. However, the investigation of several antiglucocorticoid therapies has yielded equivocal results in reducing cocaine-related behaviors, possibly because of varying mechanisms of actions. Specifically, research suggests that metyrapone (a corticosterone synthesis inhibitor) may reduce cocaine self-administration in rats via a nongenomic, extra-adrenal mechanism without altering plasma corticosterone. In the current experiments, male rats were trained to self-administer cocaine infusions and food pellets in a multiple, alternating schedule of reinforcement. Metyrapone pretreatment dose-dependently decreased cocaine self-administration as demonstrated previously. Pharmacological inhibition of neurosteroid production by finasteride had significant effects on cocaine self-administration, regardless of metyrapone pretreatment. However, metyrapone's effects on cocaine self-administration were significantly attenuated with bicuculline pretreatment, suggesting a role for GABA-active neurosteroids in cocaine-reinforced behaviors. In vitro binding data also confirmed that metyrapone does not selectively bind to GABA-related proteins. The results of these experiments support the hypothesis that metyrapone may increase neurosteroidogenesis to produce effects on cocaine-related behaviors.</abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>24959859</pmid><doi>10.1016/j.bbr.2014.06.032</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6901-3227</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0166-4328 |
ispartof | Behavioural brain research, 2014-09, Vol.271, p.269-276 |
issn | 0166-4328 1872-7549 |
language | eng |
recordid | cdi_proquest_miscellaneous_1627963031 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | 5-alpha Reductase Inhibitors - administration & dosage 5-alpha Reductase Inhibitors - pharmacology Animals Bicuculline Bicuculline - administration & dosage Bicuculline - pharmacology Biological and medical sciences Cocaine Cocaine - administration & dosage Cocaine - pharmacology Cocaine-Related Disorders - drug therapy Cocaine-Related Disorders - metabolism Conditioning, Operant - drug effects Drug-Seeking Behavior - drug effects Enzyme Inhibitors - pharmacology Finasteride Finasteride - administration & dosage Finasteride - pharmacology Food Fundamental and applied biological sciences. Psychology GABA GABA-A Receptor Antagonists - administration & dosage GABA-A Receptor Antagonists - pharmacology Male Medical sciences Metyrapone Metyrapone - pharmacology Neuropharmacology Neurosteroid Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Rats, Wistar Reinforcement (Psychology) Self Administration - methods Vertebrates: nervous system and sense organs |
title | Role of GABA-active neurosteroids in the efficacy of metyrapone against cocaine addiction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20GABA-active%20neurosteroids%20in%20the%20efficacy%20of%20metyrapone%20against%20cocaine%20addiction&rft.jtitle=Behavioural%20brain%20research&rft.au=Schmoutz,%20Christopher%20D.&rft.date=2014-09-01&rft.volume=271&rft.spage=269&rft.epage=276&rft.pages=269-276&rft.issn=0166-4328&rft.eissn=1872-7549&rft.coden=BBREDI&rft_id=info:doi/10.1016/j.bbr.2014.06.032&rft_dat=%3Cproquest_cross%3E1627963031%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1627963031&rft_id=info:pmid/24959859&rft_els_id=S0166432814004069&rfr_iscdi=true |